Article

Pharmacy Clinical Pearl of the Day: Amyotrophic Lateral Sclerosis

ALS results in muscles that are reduced in size (atrophic), weak, and soft, or muscles that are stiff, tight, and spastic.

Clinical Pearl of the Day: Amyotrophic lateral sclerosis (ALS) disease

ALS is a disease that impacts the parts of the nervous system that control voluntary muscle movement.

Explanation:

  • ALS is the most common form of motor neuron disease.
  • As these motor neurons are lost, the muscles they control become weak and then nonfunctional, thus leading to muscle weakness, disability, and eventually death.
  • ALS usually strikes in late middle age (the late 50s is average) or later.
  • ALS results in muscles that are reduced in size (atrophic), weak, and soft, or muscles that are stiff, tight, and spastic.
  • Treatment options may include medications such as Rilutek, Radicava, breathing care, physical therapy, occupational therapy, speech therapy, nutitional and psychosocial therapy.

Sources:

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com